Phase 0 3 trials
Phase 0
NCT06942039 Sep 2025 → Dec 2030 expected atypical teratoid rhabdoid tumor , childhood medulloblastoma , embryonal tumor with multilayered rosettes , ependymoblastoma +5 C17 Council
Recruiting
No outcome recorded
Phase 0
NCT04174352 Oct 2020 → Dec 2026 expected estrogen-receptor positive breast cancer University of Wisconsin, Madison
Recruiting
No outcome recorded
Phase 0
NCT02089386 Jul 2014 → Jun 2016 Barrett esophagus Washington University School of Medicine
Terminated
No outcome recorded
Stop: Business
Phase 1 17 trials
Phase 1
NCT06320990 Jan 2025 → Nov 2028 expected pancreatic mucinous-cystic neoplasm University of Nebraska
Recruiting
No outcome recorded
Phase 1
NCT05156892 Sep 2022 → Jan 2026 overdue ovarian carcinoma Anthony Joshua, FRACP
Active not recruiting
No outcome recorded
Phase 1
NCT04200066 Jun 2022 → Oct 2023 brain neoplasm , glioblastoma University of Rochester
Withdrawn
No outcome recorded
Phase 1
NCT04961632 Dec 2020 → Nov 2025 breast cancer National Cancer Centre, Singapore
Unknown
No outcome recorded
Phase 1
NCT04433494 Dec 2020 → May 2023 breast cancer TYK Medicines, Inc
Unknown
No outcome recorded
Phase 1
NCT03554044 Feb 2020 → Dec 2023 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma , invasive breast carcinoma University of California, San Francisco
Completed
No outcome recorded
Phase 1
NCT02835079 Nov 2016 → Nov 2020 Duchenne muscular dystrophy Hadassah Medical Organization
Completed
No outcome recorded
Phase 1
NCT02513849 Dec 2015 → Aug 2018 cancer , digestive system neoplasm University of Nottingham
Unknown
No outcome recorded
Phase 1
NCT02333370 Feb 2015 → Sep 2022 hormone receptor-positive breast cancer Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT02093351 Sep 2014 → Apr 2015 cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT02057133 Mar 2014 → Mar 2021 overdue breast neoplasm Eli Lilly and Company
Active not recruiting
No outcome recorded
Phase 1
NCT01821066 Apr → Aug 2013 —
Pfizer
Completed
No outcome recorded
Phase 1
NCT01192308 Jul 2010 → May 2011 breast cancer Radboud University Medical Center
Completed
No outcome recorded
Phase 1
NCT00749138 Nov 2008 → May 2009 chronic hepatitis C virus infection Bader, Ted, M.D.
Completed
No outcome recorded
Phase 1
NCT00424164 Nov 2006 → Jun 2009 breast cancer European Organisation for Research and Treatment of Cancer - EORTC
Completed
No outcome recorded
Phase 1
NCT00005886 Jul 2000 → Aug 2002 breast cancer University of Kansas Medical Center
Completed
No outcome recorded
Phase 1
NCT00001436 May 1995 → Sep 2000 metastatic neoplasm , osteosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Show 7 more trials Phase 1/2 7 trials · 1 missed
Phase 1/2
NCT05378269 Nov 2021 → Dec 2022 skin atrophy Daré Bioscience, Inc.
Completed
No outcome recorded
Phase 1/2
NCT04915846 Dec 2020 → May 2024 X-linked myotubular myopathy James Dowling
Terminated
No outcome recorded
Phase 1/2
NCT03280563 Dec 2017 → Sep 2024 breast neoplasm Hoffmann-La Roche
Completed
Missed primary
Phase 1/2
NCT04079517 Mar 2015 → Feb 2016 breast cancer Karolinska Institutet
Completed
No outcome recorded
Phase 1/2
NCT02166944 Apr 2014 → Sep 2019 amyotrophic lateral sclerosis Taipei Medical University Shuang Ho Hospital
Completed
No outcome recorded
Phase 1/2
NCT01194908 Jul 2010 → Jan 2014 breast cancer Emory University
Terminated
No outcome recorded
Stop: Enrollment
Phase 1/2
NCT00290745 Feb 2002 → Jul 2009 breast cancer University of California, San Francisco
Completed
Mixed
Phase 2 108 trials · 5 met primary · 8 missed
Phase 2
NCT07499999 Sep 2026 → Aug 2027 expected ATM-related cancer predisposition , BRCA2-related cancer predisposition , CHEK2-related cancer predisposition , atypical lobular breast hyperplasia +1 Dana-Farber Cancer Institute
Not yet recruiting
No outcome recorded
Phase 2
NCT07806630 Sep 2026 → Jul 2028 expected invasive breast carcinoma Rutgers, The State University of New Jersey
Active not recruiting
No outcome recorded
Phase 2
NCT07535905 Jul 2026 → Oct 2030 expected hypogonadism , prostate cancer University Health Network, Toronto
Not yet recruiting
No outcome recorded
Phase 2
NCT07483307 Mar 2026 → Mar 2030 expected Her2-receptor negative breast cancer , breast lobular carcinoma , estrogen-receptor positive breast cancer Memorial Sloan Kettering Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT06434064 Mar 2026 → Nov 2028 expected triple-negative breast carcinoma Roswell Park Cancer Institute
Recruiting
No outcome recorded
Phase 2
NCT07289035 Jan → Apr 2026 overdue cystic fibrosis Azienda Ospedaliera Universitaria Integrata Verona
Not yet recruiting
No outcome recorded
Phase 2
NCT06364267 Oct 2025 → Jan 2027 expected breast cancer Andrea DeCensi
Recruiting
No outcome recorded
Phase 2
NCT06979596 Aug 2025 → Nov 2027 expected cancer Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 2
NCT06195306 Jul 2025 → Jan 2027 expected ductal breast carcinoma in situ , lobular breast carcinoma in situ National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT06630325 Jun 2025 → Mar 2026 exocrine pancreatic carcinoma , female breast carcinoma , ovarian carcinoma , prostate carcinoma +1 OHSU Knight Cancer Institute
Terminated
No outcome recorded
Phase 2
NCT06914674 Mar 2025 → Feb 2027 expected malignant pancreatic neoplasm Fudan University
Recruiting
No outcome recorded
Phase 2
NCT06361940 Sep 2024 → Dec 2028 expected breast cancer Medical College of Wisconsin
Recruiting
No outcome recorded
Phase 2
NCT06184750 Sep 2024 → Mar 2028 expected atypical lobular breast hyperplasia , ductal breast carcinoma in situ , estrogen-receptor positive breast cancer , lobular breast carcinoma in situ National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT05501704 Oct 2023 → Apr 2027 expected hormone receptor-positive breast cancer , male breast carcinoma Jose Pablo Leone
Recruiting
No outcome recorded
Phase 2
NCT06837792 Oct 2023 → Oct 2026 expected Her2-receptor negative breast cancer Yonsei University
Recruiting
No outcome recorded
Phase 2
NCT05826964 Jun 2023 → Jul 2026 overdue Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer University of Miami
Active not recruiting
No outcome recorded
Phase 2
NCT05101564 Mar 2023 → Jun 2024 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer Jennifer Lee Caswell-Jin
Completed
No outcome recorded
Phase 2
NCT05669768 Jan 2023 → Jul 2024 ovarian cancer Sun Yat-sen University
Unknown
No outcome recorded
Phase 2
NCT05133674 Apr → Dec 2022 breast carcinoma Karolinska University Hospital
Unknown
No outcome recorded
Phase 2
NCT05150652 Feb 2022 → Dec 2025 Her2-receptor negative breast cancer Irada Ibrahim-zada
Completed
No outcome recorded
Phase 2
NCT04765098 Jan 2022 → Dec 2026 expected glioblastoma AHS Cancer Control Alberta
Recruiting
No outcome recorded
Phase 2
NCT04997941 Oct 2021 → Dec 2024 overdue hormone receptor-positive breast cancer Seoul National University Hospital
Active not recruiting
No outcome recorded
Phase 2
NCT05200663 Oct 2021 → Oct 2022 oligoasthenoteratozoospermia Sharif Medical Research Center
Unknown
No outcome recorded
Phase 2
NCT04383275 Aug 2021 → May 2025 overdue breast cancer Fudan University
Recruiting
No outcome recorded
Phase 2
NCT04570956 Jul 2021 → Oct 2024 atypical lobular breast hyperplasia , lobular breast carcinoma in situ Mayo Clinic
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT04190056 Mar 2021 → Jun 2023 breast cancer University of California, San Francisco
Terminated
No outcome recorded
Phase 2
NCT04666961 Feb 2021 → Aug 2024 overdue ductal breast carcinoma in situ Institut Cancerologie de l'Ouest
Recruiting
No outcome recorded
Phase 2
NCT04569747 Jan 2021 → Mar 2029 expected HER2 positive breast carcinoma , hormone receptor-positive breast cancer , invasive breast carcinoma Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 2
NCT04568096 Nov → Dec 2020 lung disorder Kafrelsheikh University
Unknown
No outcome recorded
Phase 2
NCT04272801 Apr 2020 → Jun 2024 overdue female breast carcinoma Shayna Showalter, MD
Active not recruiting
No outcome recorded
Phase 2
NCT03917082 Sep 2019 → May 2026 overdue female breast carcinoma , hormone receptor-positive breast cancer British Columbia Cancer Agency
Active not recruiting
No outcome recorded
Phase 2
NCT03879174 Aug 2019 → Aug 2022 female breast carcinoma Mediclinic Middle East
Unknown
No outcome recorded
Phase 2
NCT03870399 Mar 2019 → May 2023 estrogen-receptor positive breast cancer , neuroendocrine neoplasm , progesterone-receptor positive breast cancer AC Camargo Cancer Center
Completed
No outcome recorded
Phase 2
NCT04129216 Feb 2019 → Nov 2022 breast cancer Johns Hopkins University
Completed
No outcome recorded
Phase 2
NCT03691493 Feb 2019 → Oct 2022 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma , metastatic carcinoma in the bone +1 Emory University
Completed
No outcome recorded
Phase 2
NCT03528902 Oct 2018 → Jun 2023 heritable pulmonary arterial hypertension , lung disorder Vanderbilt University Medical Center
Completed
No outcome recorded
Phase 2
NCT03382834 Apr → Dec 2018 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID)
Completed
Missed primary
Phase 2
NCT03906669 Mar 2018 → Apr 2024 female breast carcinoma , hormone receptor-positive breast cancer St Vincent's Hospital
Unknown
No outcome recorded
Phase 2
NCT03112031 Oct 2017 → Jul 2018 HIV infectious disease , meningoencephalitis , streptococcal meningitis Oxford University Clinical Research Unit, Vietnam
Completed
Missed primary
Phase 2
NCT03272477 Oct 2017 → Jul 2020 breast cancer Palleos Healthcare GmbH
Completed
Met primary
Phase 2
NCT03045653 Sep 2017 → Feb 2019 breast carcinoma Sun Yat-sen University
Completed
No outcome recorded
Phase 2
NCT03211572 Aug 2017 → Aug 2018 breast cancer Ottawa Hospital Research Institute
Unknown
No outcome recorded
Phase 2
NCT03161353 Jun 2017 → Nov 2023 overdue breast cancer MedSIR
Active not recruiting
Met primary
Phase 2
NCT02988986 Apr 2017 → Feb 2019 estrogen-receptor positive breast cancer The Methodist Hospital Research Institute
Completed
No outcome recorded
Phase 2
NCT02788201 Mar 2017 → Oct 2019 urinary bladder cancer , urothelial carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT03219476 Feb 2017 → Feb 2020 invasive breast carcinoma Medical College of Wisconsin
Completed
No outcome recorded
Phase 2
NCT02668666 Feb 2017 → Jul 2023 hormone receptor-positive breast cancer Oana Danciu, MD
Completed
No outcome recorded
Phase 2
NCT02476786 Jan 2017 → Jan 2027 expected breast cancer Washington University School of Medicine
Recruiting
No outcome recorded
Phase 2
NCT03346200 Nov 2016 → Oct 2019 Mammastatin Per Hall
Completed
Met primary
Phase 2
NCT02747004 Sep 2016 → Jun 2018 overdue breast cancer Eli Lilly and Company
Active not recruiting
Missed primary
Phase 2
NCT02764541 May 2016 → Feb 2022 overdue breast cancer Dana-Farber Cancer Institute
Active not recruiting
Mixed
Phase 2
NCT02624973 Apr 2016 → Jun 2020 overdue breast cancer Haukeland University Hospital
Active not recruiting
No outcome recorded
Phase 2
NCT03204734 Jan 2016 → Dec 2020 breast cancer Zhejiang Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT02448420 Jul 2015 → Sep 2023 breast cancer SOLTI Breast Cancer Research Group
Completed
No outcome recorded
Phase 2
NCT02311933 May 2015 → Nov 2020 overdue breast carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02395627 May 2015 → Jun 2019 breast neoplasm University of California, San Francisco
Terminated
No outcome recorded
Phase 2
NCT02482740 May 2015 → Jan 2017 cervical squamous cell carcinoma Buddhist Tzu Chi General Hospital
Unknown
No outcome recorded
Phase 2
NCT02197897 Apr 2015 → Sep 2017 urinary bladder cancer Baylor College of Medicine
Completed
No outcome recorded
Phase 2
NCT02603679 Feb 2015 → Jul 2021 overdue estrogen-receptor positive breast cancer Thomas Hatschek
Active not recruiting
Missed primary
Phase 2
NCT02322853 Jan 2015 → Apr 2017 breast cancer Centre Francois Baclesse
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT02890082 Feb 2014 → Jul 2017 overdue female breast carcinoma Institut Cancerologie de l'Ouest
Active not recruiting
No outcome recorded
Phase 2
NCT01973660 Oct 2013 → Jun 2016 breast cancer SOLTI Breast Cancer Research Group
Completed
No outcome recorded
Phase 2
NCT02806544 Jan 2013 → Sep 2014 breast cancer Vanderbilt University
Completed
No outcome recorded
Phase 2
NCT01771458 Oct 2012 → Oct 2016 refractory malignant neoplasm Institut Curie
Completed
Missed primary
Phase 2
NCT01614210 Aug 2012 → Nov 2016 hormone receptor-positive breast cancer University of Utah
Completed
Met primary
Phase 2
NCT02866955 Jun 2011 → Aug 2014 breast cancer Institut de Cancérologie de Lorraine
Completed
No outcome recorded
Phase 2
NCT01257581 Mar 2011 → Dec 2012 amyotrophic lateral sclerosis Nazem Atassi
Completed
No outcome recorded
Phase 2
NCT01194427 Mar → Nov 2011 female breast carcinoma , invasive breast carcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT01124695 Jan 2011 → Nov 2020 breast cancer ECOG-ACRIN Cancer Research Group
Completed
No outcome recorded
Phase 2
NCT01196936 Sep 2010 → Dec 2018 overdue breast cancer University of Alabama at Birmingham
Active not recruiting
Missed primary
Phase 2
NCT01220076 Sep 2009 → Oct 2016 breast cancer Institut Cancerologie de l'Ouest
Completed
No outcome recorded
Phase 2
NCT00866554 Mar 2009 → Mar 2019 erectile dysfunction , prostate cancer CHU de Quebec-Universite Laval
Completed
No outcome recorded
Phase 2
NCT00729586 Sep 2008 → Feb 2017 endometrial carcinoma , uterine corpus cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00738777 Jul 2008 → Jun 2022 breast cancer The Netherlands Cancer Institute
Suspended
No outcome recorded
Phase 2
NCT00764322 Jun 2008 → Sep 2010 breast cancer UNC Lineberger Comprehensive Cancer Center
Completed
No outcome recorded
Phase 2
NCT01298713 Mar 2008 → Jun 2011 MTOR-related overgrowth spectrum , breast neoplasm ARCAGY/ GINECO GROUP
Completed
No outcome recorded
Phase 2
NCT00489944 May 2007 → Dec 2012 ocular melanoma San Diego Pacific Oncology & Hematology Associates
Unknown
No outcome recorded
Phase 2
NCT00492505 Apr 2007 → Dec 2011 cutaneous melanoma San Diego Pacific Oncology & Hematology Associates
Unknown
No outcome recorded
Phase 2
NCT00710970 Jan 2007 → Dec 2011 urinary bladder neoplasm Seth Lerner
Completed
No outcome recorded
Phase 2
NCT00492687 Dec 2006 → Jul 2009 central nervous system cancer San Diego Pacific Oncology & Hematology Associates
Unknown
No outcome recorded
Phase 2
NCT00532454 Jun 2006 breast cancer , metastatic neoplasm National Cancer Center, Korea
Terminated
No outcome recorded
Phase 2
NCT00499083 May 2006 → Jul 2009 breast cancer University of Nebraska
Completed
No outcome recorded
Phase 2
NCT00365599 Feb 2006 → Apr 2011 breast cancer H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 2
NCT00118157 May 2005 → Jul 2011 estrogen-receptor positive breast cancer , female breast carcinoma , male breast carcinoma , progesterone-receptor positive breast cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00108069 Apr 2005 → Mar 2013 glioma National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT00375622 Feb 2005 → Jun 2006 hereditary hemorrhagic telangiectasia Rabin Medical Center
Completed
No outcome recorded
Phase 2
NCT00305838 Mar 2004 → Dec 2008 fallopian tube cancer , ovarian cancer , peritoneum cancer Mount Vernon Cancer Centre at Mount Vernon Hospital
Unknown
No outcome recorded
Phase 2
NCT00068419 Feb 2004 → Apr 2010 desmoid tumor Children's Oncology Group
Completed
No outcome recorded
Phase 2
NCT00194779 Oct 2003 → Jun 2010 HER2 positive breast carcinoma , estrogen-receptor negative breast cancer , estrogen-receptor positive breast cancer , female breast carcinoma +2 University of Washington
Completed
No outcome recorded
Phase 2
NCT00206492 Jul 2003 → Oct 2006 breast cancer Baylor Breast Care Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00541138 May 2003 → Oct 2007 central nervous system neoplasm , metastatic malignant neoplasm City of Hope Medical Center
Completed
No outcome recorded
Phase 2
NCT00052728 Dec 2002 → Jul 2006 breast cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01831076 Apr 2002 → Feb 2013 female breast carcinoma University of Colorado, Denver
Completed
No outcome recorded
Phase 2
NCT00919399 Jan 2002 → Jun 2006 breast neoplasm Institut Claudius Regaud
Completed
No outcome recorded
Phase 2
NCT00253539 Jan 2002 → Apr 2005 breast cancer , hereditary breast ovarian cancer syndrome The Cleveland Clinic
Completed
No outcome recorded
Phase 2
NCT00026585 Nov 2001 → Nov 2007 bipolar disorder National Institute of Mental Health (NIMH)
Completed
No outcome recorded
Phase 2
NCT00033683 Feb 2001 → ? breast cancer Institute of Cancer Research, United Kingdom
Unknown
No outcome recorded
Phase 2
NCT00214110 Jan 2001 → Jan 2005 amyotrophic lateral sclerosis University of Wisconsin, Madison
Completed
No outcome recorded
Phase 2
NCT00006388 Dec 2000 → Oct 2003 central nervous system neoplasm Radiation Therapy Oncology Group
Completed
Missed primary
Phase 2
NCT00440349 Oct 2000 → Apr 2007 —
University of Parma
Unknown
Met primary
Phase 2
NCT00295100 Sep 2000 → Jul 2006 breast cancer University of Pennsylvania
Completed
No outcome recorded
Phase 2
NCT00007904 Jul 2000 → Jun 2006 breast cancer Case Comprehensive Cancer Center
Completed
No outcome recorded
Phase 2
NCT00096369 Feb 2000 → Mar 2007 breast cancer University of Texas Southwestern Medical Center
Terminated
No outcome recorded
Stop: Enrollment
Phase 2
NCT00024336 Aug 1999 → ? central nervous system neoplasm Children's Cancer and Leukaemia Group
Unknown
No outcome recorded
Phase 2
NCT00543829 Apr 1998 → Jun 1999 breast neoplasm GBG Forschungs GmbH
Completed
No outcome recorded
Phase 2
NCT00002608 May 1994 → Apr 2005 adrenal cortex carcinoma , central nervous system neoplasm , head and neck cancer , liver cancer +3 Ottawa Regional Cancer Centre
Completed
No outcome recorded
Phase 2
NCT00002680 Feb 1994 → Dec 2000 breast cancer Yale University
Completed
No outcome recorded
Phase 2
NCT00189358 — fallopian tube cancer , ovarian carcinoma , peritoneum cancer AGO Study Group
Completed
No outcome recorded
Show 98 more trials Phase 2/3 4 trials
Phase 2/3
NCT06355401 Apr 2024 → Mar 2026 overdue diffuse large B-cell lymphoma Sohag University
Not yet recruiting
No outcome recorded
Phase 2/3
NCT02801786 Nov 2018 → Nov 2020 —
Federal University of Goiás
Unknown
No outcome recorded
Phase 2/3
NCT03373708 Dec 2017 → Dec 2019 breast cancer Zhiyong Yu
Unknown
No outcome recorded
Phase 2/3
NCT02132000 Apr 2014 → May 2020 hormone receptor-positive breast cancer Fengxi Su
Unknown
No outcome recorded
Phase 3 58 trials · 7 met primary · 8 missed
Phase 3
NCT07502820 Mar 2026 → Aug 2036 expected female breast carcinoma Karolinska Institutet
Not yet recruiting
No outcome recorded
Phase 3
NCT07671885 Jan 2026 → Jan 2038 expected breast cancer Tokyo Women's Medical University
Recruiting
No outcome recorded
Phase 3
NCT07153757 Sep 2025 → Sep 2033 expected female breast carcinoma Fudan University
Not yet recruiting
No outcome recorded
Phase 3
NCT06223698 May 2025 → May 2032 expected breast cancer Region Örebro County
Not yet recruiting
No outcome recorded
Phase 3
NCT06671912 Feb 2025 → Nov 2030 Her2-receptor negative breast cancer , ductal breast carcinoma in situ , estrogen-receptor positive breast cancer , lobular breast carcinoma in situ Alliance for Clinical Trials in Oncology
Suspended
No outcome recorded
Phase 3
NCT06492616 Sep 2024 → Aug 2029 expected breast cancer Stemline Therapeutics, Inc.
Recruiting
No outcome recorded
Phase 3
NCT06507618 Jul 2024 → Jun 2029 expected female breast carcinoma University of Virginia
Recruiting
No outcome recorded
Phase 3
NCT07616973 May 2023 → May 2026 overdue female infertility Sana'a University
Active not recruiting
No outcome recorded
Phase 3
NCT05016349 Aug → Oct 2021 female breast carcinoma Mahmoud Ramadan mohamed Elkazzaz
Unknown
No outcome recorded
Phase 3
NCT04046159 Apr 2019 → Dec 2025 ductal breast carcinoma in situ National Taiwan University Hospital
Unknown
No outcome recorded
Phase 3
NCT03354039 Jun 2018 → Jul 2022 Duchenne muscular dystrophy University Hospital, Basel, Switzerland
Completed
Missed primary
Phase 3
NCT03011684 Jul 2016 → Mar 2028 expected infertility disorder University of California, San Francisco
Recruiting
Missed primary
Phase 3
NCT02535221 Jul 2015 → Jun 2026 overdue breast cancer Peking University
Recruiting
No outcome recorded
Phase 3
NCT02097459 Mar 2014 → Mar 2024 breast cancer Peking Union Medical College Hospital
Unknown
No outcome recorded
Phase 3
NCT01950182 Sep 2013 → May 2020 breast cancer Sun Yat-sen University
Completed
No outcome recorded
Phase 3
NCT01622361 Jun 2012 → Feb 2016 breast cancer Asan Medical Center
Unknown
Missed primary
Phase 3
NCT00963209 Jun 2009 → Sep 2013 breast cancer Centre Hospitalier Universitaire Vaudois
Unknown
No outcome recorded
Phase 3
NCT00912548 May 2009 → Dec 2015 breast cancer Korean Breast Cancer Study Group
Unknown
Met primary
Phase 3
NCT00893061 Mar 2009 → Apr 2012 breast cancer Centre Oscar Lambret
Completed
No outcome recorded
Phase 3
NCT00949598 Dec 2008 → Oct 2010 breast cancer Institut du Cancer de Montpellier - Val d'Aurelle
Completed
No outcome recorded
Phase 3
NCT00896155 Dec 2008 → Dec 2011 breast cancer , pulmonary fibrosis Tata Memorial Hospital
Unknown
No outcome recorded
Phase 3
NCT01357772 Nov 2008 → Dec 2022 overdue ductal breast carcinoma in situ , hyperplasia Andrea DeCensi
Active not recruiting
Met primary
Phase 3
NCT00601900 Sep 2008 → Jun 2014 invasive breast carcinoma National Cancer Institute (NCI)
Completed
Met primary
Phase 3
NCT01352091 May 2008 → May 2015 breast cancer Fudan University
Unknown
No outcome recorded
Phase 3
NCT00659373 Dec 2007 → Dec 2014 breast cancer , sleep disorder ETOP IBCSG Partners Foundation
Completed
Missed primary
Phase 3
NCT00171704 Apr 2005 → Mar 2011 hormone receptor-positive breast cancer Novartis Pharmaceuticals
Completed
No outcome recorded
Phase 3
NCT00066690 Dec 2003 → May 2014 estrogen-receptor positive breast cancer , female breast carcinoma , progesterone-receptor positive breast cancer ETOP IBCSG Partners Foundation
Completed
Missed primary
Phase 3
NCT00233610 Dec 2003 → Oct 2007 prostate cancer AstraZeneca
Completed
No outcome recorded
Phase 3
NCT00066807 Aug 2003 → Dec 2006 breast cancer ETOP IBCSG Partners Foundation
Terminated
No outcome recorded
Stop: Enrollment
Phase 3
NCT00041080 Feb 2003 → Jan 2011 fallopian tube cancer , malignant epithelial tumor of ovary , peritoneum cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 3
NCT02728622 Mar 2002 → Jan 2008 fallopian tube carcinoma , ovarian carcinoma , peritoneal carcinoma Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Completed
No outcome recorded
Phase 3
NCT00032136 Dec 2001 → Apr 2009 breast cancer Cancer Research Campaign Clinical Trials Centre
Completed
Missed primary
Phase 3
NCT00687102 Oct 2001 → Mar 2008 —
Wake Forest University
Completed
No outcome recorded
Phase 3
NCT00036270 Aug 2001 → Oct 2008 breast neoplasm Pfizer
Completed
Missed primary
Phase 3
NCT00016341 May 2001 → Oct 2003 endometrial cancer Gynecologic Oncology Group
Terminated
No outcome recorded
Phase 3
NCT00232661 Aug 2000 → Jan 2003 breast cancer AstraZeneca
Completed
No outcome recorded
Phase 3
NCT00003857 Dec 1999 → Feb 2004 breast cancer Radiation Therapy Oncology Group
Completed
Met primary
Phase 3
NCT00004205 Mar 1998 → Dec 2008 breast cancer ETOP IBCSG Partners Foundation
Completed
Met primary
Phase 3
NCT00003418 Feb 1998 → ? breast cancer International Collaborative Cancer Group
Unknown
Met primary
Phase 3
NCT00010140 Aug 1997 → ? breast cancer International Collaborative Cancer Group
Unknown
No outcome recorded
Phase 3
NCT00003424 Apr 1997 → Jun 2000 liver cancer National Medical Research Council (NMRC), Singapore
Completed
No outcome recorded
Phase 3
NCT00002777 May 1996 → Dec 2002 breast cancer European Organisation for Research and Treatment of Cancer - EORTC
Completed
Missed primary
Phase 3
NCT00291759 Jan 1996 → Jun 2009 breast cancer AstraZeneca
Completed
No outcome recorded
Phase 3
NCT00003016 Oct 1995 → ? breast cancer University of Oxford
Unknown
No outcome recorded
Phase 3
NCT00002644 Jan 1994 → Jan 2001 breast cancer Queen Mary University of London
Completed
Met primary
Phase 3
NCT00002542 Jul 1993 → Mar 2007 breast cancer NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 3
NCT00002581 Jun 1993 → ? breast cancer Scottish Cancer Therapy Network
Completed
No outcome recorded
Phase 3
NCT00002580 Jun 1993 → ? breast cancer Scottish Cancer Therapy Network
Completed
No outcome recorded
Phase 3
NCT00002529 May 1993 → Aug 2010 breast cancer ETOP IBCSG Partners Foundation
Completed
No outcome recorded
Phase 3
NCT00002579 Mar 1993 → ? breast cancer Scottish Cancer Therapy Network
Completed
No outcome recorded
Phase 3
NCT00000529 May 1992 → Nov 1995 coronary artery disorder , hypertensive disorder , myocardial ischemia NSABP Foundation Inc
Completed
No outcome recorded
Phase 3
NCT00006030 Jan 1992 → ? breast cancer British Association of Surgical Oncology: Breast Group
Unknown
No outcome recorded
Phase 3
NCT00003678 May 1991 → ? breast cancer University Hospital Birmingham
Unknown
No outcome recorded
Phase 3
NCT00309478 Dec 1990 → Jun 2004 female breast carcinoma Austrian Breast & Colorectal Cancer Study Group
Completed
No outcome recorded
Phase 3
NCT00929591 May 1989 → Aug 2005 breast cancer SWOG Cancer Research Network
Completed
No outcome recorded
Phase 3
NCT00002460 Sep 1987 → ? female breast carcinoma Cancer Research UK
Unknown
No outcome recorded
Phase 3
NCT00053339 — female breast carcinoma Alliance for Clinical Trials in Oncology
Withdrawn
No outcome recorded
Phase 3
NCT00034125 — breast cancer Eli Lilly and Company
Completed
No outcome recorded
Show 48 more trials Phase 4 15 trials · 1 met primary
Phase 4
NCT05333328 Feb 2023 → Jan 2031 expected Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer Gangnam Severance Hospital
Recruiting
No outcome recorded
Phase 4
NCT05525481 Nov 2022 → Dec 2023 estrogen-receptor positive breast cancer Erasmus Medical Center
Unknown
No outcome recorded
Phase 4
NCT03948568 Sep 2019 → Jun 2021 female breast carcinoma Ottawa Hospital Research Institute
Completed
No outcome recorded
Phase 4
NCT03238703 Sep 2018 → Mar 2023 Her2-receptor negative breast cancer , breast carcinoma in situ , female breast carcinoma , invasive breast carcinoma Fred Hutchinson Cancer Center
Withdrawn
No outcome recorded
Stop: Enrollment
Phase 4
NCT03355157 Mar 2018 → Aug 2024 breast cancer GBG Forschungs GmbH
Completed
No outcome recorded
Phase 4
NCT03060304 Mar 2017 → Dec 2019 endometrial disorder Sun Yat-sen University
Unknown
No outcome recorded
Phase 4
NCT02903121 Jan 2017 → Jun 2019 hemorrhagic disease Oregon Health and Science University
Completed
No outcome recorded
Phase 4
NCT02690870 Jan 2017 → May 2018 infertility disorder Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
No outcome recorded
Phase 4
NCT02824224 Sep 2016 → Jan 2018 hemometra , menstrual disorder Oregon Health and Science University
Completed
No outcome recorded
Phase 4
NCT02479256 Jun 2015 → May 2016 polycystic ovary syndrome Ain Shams University
Completed
No outcome recorded
Phase 4
NCT02070692 Feb 2014 → Dec 2015 menstrual disorder Oregon Health and Science University
Completed
No outcome recorded
Phase 4
NCT01553903 Dec 2011 → May 2013 breast cancer Institut Claudius Regaud
Completed
No outcome recorded
Phase 4
NCT01189500 Aug → Oct 2010 —
Pfizer
Completed
Met primary
Phase 4
NCT01127295 Jun 2010 → Dec 2017 hormone receptor-positive breast cancer Institut Claudius Regaud
Completed
No outcome recorded
Phase 4
NCT00999921 Jan 2008 → Aug 2014 benign mammary dysplasia , breast fibroadenoma , breast fibrocystic disease Medical College and Hospital Kolkata
Completed
No outcome recorded
Show 5 more trials Phase not applicable 11 trials
— NCT05501158 Jan 2021 → Apr 2024 breast cancer Nalagenetics Pte Ltd
Unknown
No outcome recorded
— NCT04312347 Sep 2019 → May 2021 estrogen-receptor positive breast cancer Nalagenetics Pte Ltd
Completed
No outcome recorded
— NCT02979301 Mar 2017 → Feb 2018 —
Mayo Clinic
Completed
No outcome recorded
— NCT01293032 Apr 2011 → May 2015 ductal breast carcinoma in situ , female breast carcinoma , lobular breast carcinoma in situ Virginia Commonwealth University
Completed
No outcome recorded
— NCT01075802 Mar 2010 → Oct 2012 Amobarbital, deficient N-hydroxylation of , breast cancer Western Sydney Local Health District
Completed
No outcome recorded
— NCT00847366 May 2008 → Dec 2012 breast cancer , non-small cell lung carcinoma , sarcoma AEterna Zentaris
Completed
No outcome recorded
— NCT00538330 Sep 2007 → Sep 2020 breast cancer King Faisal Specialist Hospital & Research Center
Unknown
No outcome recorded
— NCT00449514 May 2007 → ? infertility disorder Shaare Zedek Medical Center
Unknown
No outcome recorded
— NCT01016665 Apr 2005 → Jul 2007 breast cancer Federal University of São Paulo
Completed
No outcome recorded
— NCT00126464 Nov 2004 → ? breast cancer Cedars-Sinai Medical Center
Unknown
No outcome recorded
— NCT00165308 Apr 2001 → Mar 2004 Hodgkins lymphoma , breast cancer Dana-Farber Cancer Institute
Completed
No outcome recorded
Show 1 more trial Comparator or background therapy 194 trials
Phase 0
NCT02913430 Comparator Apr 2018 → Apr 2022 breast cancer Shannon Puhalla
Completed
No outcome recorded
Phase 1
NCT06218303 Background Feb 2024 → Aug 2026 overdue ductal breast carcinoma in situ Finn, Olivera, PhD
Recruiting
No outcome recorded
Phase 1
NCT05755581 Comparator Apr 2023 → Apr 2025 breast cancer Sohag University
Unknown
No outcome recorded
Phase 1
NCT04504331 Background Oct 2020 → Oct 2021 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , progesterone-receptor positive breast cancer Jennifer Lee Caswell-Jin
Terminated
No outcome recorded
Phase 1
NCT02936206 Comparator Oct 2016 → May 2020 breast cancer Icahn School of Medicine at Mount Sinai
Terminated
No outcome recorded
Stop: Enrollment
Show all 194 trials opens the full record — a long page